Mark Schoenebaum - Net Worth and Insider Trading
Mark Schoenebaum Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Mark Schoenebaum owns 3 companies in total, including Immunovant Inc (IMVTU) , TG Therapeutics Inc (TGTX) , and Immunovant Inc (IMVT) .
Click here to see the complete history of Mark Schoenebaum’s form 4 insider trades.
Insider Ownership Summary of Mark Schoenebaum
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
IMVTU | Immunovant Inc | 2019-05-09 | director |
TGTX | TG Therapeutics Inc | 2012-04-16 | director |
IMVT | Immunovant Inc | 2019-05-09 | director |
Mark Schoenebaum Trading Performance
Mark Schoenebaum Ownership Network
Mark Schoenebaum Owned Company Details
What does Immunovant Inc do?
Who are the key executives at Immunovant Inc?
Mark Schoenebaum is the director of Immunovant Inc. Other key executives at Immunovant Inc include 10 percent owner Roivant Sciences Ltd. , Chief Dev. & Tech. Officer Julia G. Butchko , and Chief Scientific Officer Michael James Elliott .
Immunovant Inc (IMVTU) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Immunovant Inc (IMVTU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Immunovant Inc (IMVTU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Immunovant Inc (IMVTU)'s detailed insider trading history can be found in Insider Trading Tracker table.
Immunovant Inc Insider Transactions
Mark Schoenebaum Mailing Address
Above is the net worth, insider trading, and ownership report for Mark Schoenebaum. You might contact Mark Schoenebaum via mailing address: 787 Seventh Avenue, 48th Floor, New York Ny 10019.